Italy curbs on Pirelli allow US market competition, minister says By Investing.com

Italy’s new golden power restrictions limit Sinochem’s board representation in Pirelli to three seats and bar its appointees from chairman or CEO roles, easing governance concerns around the tire maker’s U.S. expansion. The ruling is intended to help Pirelli compete in the U.S. market amid tighter rules aimed at reducing Chinese technology influence in autos. Sinochem owns 34% of Pirelli, while Camfin holds about 26% and plans to raise its stake to 29.9%.

Analysis

The immediate beneficiary is not just Pirelli’s equity value, but its strategic optionality: governance clarity lowers the probability of a U.S. market-access discount being applied by OEMs, distributors, and regulators. In premium tires, where qualification cycles are long and switching costs are high, even a modest reduction in ownership-related uncertainty can preserve share in EV platforms and telematics-heavy applications. The second-order effect is that domestic or “cleaner governance” peers in Europe may re-rate relative to names with opaque Chinese influence, as U.S. commercial counterparties increasingly price regulatory friction into procurement decisions.

The bigger risk is that this is not a clean win, but an escalation path. Sinochem’s legal appeal can extend the overhang for months, and any perceived political interference could invite retaliation in China or complicate Pirelli’s broader Asia sourcing and sales footprint. That matters because the tire business is exposed to raw-material procurement and global auto demand; a governance-driven U.S. win is only durable if it does not trigger higher input-cost volatility or de-risking by multinational OEMs that prefer stable cross-border ownership structures.

The market may be underestimating how much this decision reinforces a broader “friend-shoring” regime in auto components. If U.S. regulators keep tightening the definition of acceptable foreign influence in connected vehicle supply chains, firms with European control and no China governance overhang should gain share in sensors, software-adjacent components, and premium replacement channels over the next 12-24 months. Conversely, any names with similar Chinese strategic stakes could face a slower path to U.S. commercialization, even absent formal sanctions.

Key Decisions for Investors

• Buy Pirelli on weakness over the next 1-4 weeks if the appeal headlines create a selloff; use that as entry for a 3-6 month trade on de-risking of U.S. market access. Risk/reward improves if the market discounts the ruling as purely political, because the operational benefit compounds over multiple sales cycles.
• Pair trade: long European auto suppliers with minimal China governance overhang / short suppliers with strategic Chinese stakes over 2-3 months. The thesis is that procurement teams and regulators will increasingly penalize governance friction before it appears in reported revenue.
• If accessible through derivatives or ADR equivalents, consider call spreads on Pirelli into the next 1-2 earnings cycles. The upside is a multiple expansion on lower perceived regulatory risk; the risk is headline-driven volatility from the Sinochem appeal.
• Avoid chasing any broad auto-software or connected-component names with significant China ownership until U.S. rules clarify enforcement. The asymmetric risk is not immediate revenue loss but delayed certification and longer OEM approval timelines, which can compress estimates quietly over 2-4 quarters.